R&D Incentives For Neglected Diseases - The Impact Of Firm Characteristics On New Product Development
Abstract
Although neglected diseases of developing countries are beginning to receive more
attention from companies because of rising interest in corporate social responsibility
and government incentive policies, the allocation of research funding to these diseases
still remains extremely low. In this study, an ordinary least square regression methodology
is used to decipher the impacts of firm-level characteristics such as revenue volume,
headquarter location, pipeline size and business structure on R&D incentives for neglected
diseases. Findings reveal that, research on neglected diseases by top 20 pharmaceutical
firms is positively correlated with spillovers from other research (including animal
health) and with European headquarters. Research on neglected diseases with greater
burdens, e.g. Malaria and TB, tends to be done by firms with the greater revenue size;
and research on the neglected diseases with smaller burdens, e.g. Dengue and Typhoid,
tends to be done by firms with somewhat smaller revenue size. Based on these findings,
appropriate policy implications are then drawn.
Type
Honors thesisDepartment
EconomicsSubject
neglected diseases, firm characteristics, revenue size, headquarter, pipeline volume,
animal healthPermalink
https://hdl.handle.net/10161/3552Citation
Ni, Chen (2011). R&D Incentives For Neglected Diseases - The Impact Of Firm Characteristics On New
Product Development. Honors thesis, Duke University. Retrieved from https://hdl.handle.net/10161/3552.Collections
More Info
Show full item record
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Rights for Collection: Undergraduate Honors Theses and Student papers
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info